Prosecution Insights
Last updated: July 17, 2026
Application No. 18/262,837

ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING A COMPOUND OF FORMULA (I) AND A COMPOUND OF FORMULA (II), AND DISPLAY DEVICE COMPRISING THE ORGANIC ELECTROLUMINESCENT DEVICE

Non-Final OA §103
Filed
Jul 25, 2023
Priority
Jun 03, 2022 — EU 22177214.8 +1 more
Examiner
DAHLBURG, ELIZABETH M
Art Unit
Tech Center
Assignee
Novaled GmbH
OA Round
1 (Non-Final)
50%
Grant Probability
Moderate
1-2
OA Rounds
1y 8m
Est. Remaining
97%
With Interview

Examiner Intelligence

Grants 50% of resolved cases
50%
Career Allowance Rate
94 granted / 188 resolved
-10.0% vs TC avg
Strong +47% interview lift
Without
With
+46.6%
Interview Lift
resolved cases with interview
Typical timeline
4y 7m
Avg Prosecution
47 currently pending
Career history
234
Total Applications
across all art units

Statute-Specific Performance

§103
83.3%
+43.3% vs TC avg
§102
2.7%
-37.3% vs TC avg
§112
4.5%
-35.5% vs TC avg
Black line = Tech Center average estimate • Based on career data from 188 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Specification Applicant is reminded of the proper language and format for an abstract of the disclosure. A patent abstract is a concise statement of the technical disclosure of the patent and should include that which is new in the art to which the invention pertains. The abstract should describe the disclosure sufficiently to assist readers in deciding whether there is a need for consulting the full patent text for details. The abstract of the disclosure is objected to because it does not appear to describe the disclosure sufficiently to assist readers in deciding whether there is a need for consulting the full patent text for details. It is the Examiner's position that at least a chemical structure formula (I) and (II) should be shown in the abstract. Correction is required. See MPEP § 608.01(b). Claim Objections Claim 1, 2, 6-8, and 11 are objected to because of the following informalities: in claim 1 it is suggested that the dashes "-" be deleted for ease of reading; in claim 1 on line 6, it is suggested that "each of the at least one charge generation layer" be changed to "each of the at least one charge generation layers" for ease of reading; in claim 1 it is suggested that Rʻ be changed to R' for ease of reading; and in claim 2 on line 4, it is suggested that "each of the at least one charge generation layer" be changed to "each of the at least one charge generation layers" for ease of reading; in clam 6, it is suggested that "said" be replaced with "the" for ease of reading; in claim 7, it is suggested that Rʼ is selected from CN be changed to "R[[ʼ]]' is CN" for ease of reading; and in claims 8 and 11, it is suggested that "are selected the same" be changed to "are. Appropriate correction is required. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claims 1-15 rejected under 35 U.S.C. 103 as being unpatentable over Ganier et al. US-20210210708-A1 (hereinafter "Ganier") in view of Cui et al. US-20200062778-A1 (hereinafter "Cui"). Regarding claims 1-15, Ganier teaches a tandem OLED comprising a charge generation layer (¶ [0650] and FIG. 7) comprising an anode electrode, a first hole injection layer (HIL), a first hole transport layer (HTL), a first electron blocking layer (EBL), a first emission layer (EML), a first hole blocking layer (HBL), an electron transport layer stack of a first electron transport layer (ETL) and a second electron transport layer (ETL) , an n-type charge generation layer (n-type CGL), a p-type charge generation layer (p-type GCL), a second hole transport layer (HTL), a second electron blocking layer (EBL), a second emission layer (EML), a second hole blocking layer (EBL), a second electron transport layer stack (ETL) of a fourth electron transport layer (ETL) and a third electron transport layer (ETL), an electron injection layer (EIL), a first cathode electrode layer, and a second cathode electrode layer (¶ [0661] and FIG. 7). Ganier further teaches a device comprising the OLED in a display or a lighting panel (¶ [0641]). Ganier teaches the device comprising two, three or four emission layers (¶ [0715]). Ganier teaches wherein the hole injection layer comprises 97 wt.-% of Biphenyl-4-yl(9,9-diphenyl-9H-fluoren-2-yl)-[4-(9-phenyl-9H-carbazol-3-yl)phenyl]-amine and 3 wt.-% of 2,2′,2″-(cyclopropane-1,2,3-triylidene)tris(2-(p-cyanotetrafluorophenyl)acetonitrile), which meets the claimed Formula (I) (¶ [0666]). The hole injection layer in the modified device of Ganier in view of Cui corresponds to the claimed organic semiconductor layer. Ganier does not specifically teach wherein the p-type charge generation layer (p-type GCL) comprises an organic hole transport material and a compound of formula (II). However, Ganier teaches the p-type GCL can be composed of organic material doped with p-type dopant (e.g. a host), wherein the p-type dopant and the host can employ conventional materials (¶ [0589]). Ganier teaches wherein the host can be one selected from a group consisting of N,N′-di(naphthalen-1-yl)-N,N-diphenyl-benzidine (NPB), N,N′-diphenyl-N,N′-bis(3-methylphenyl)-1,1-biphenyl-4,4′-diamine (TPD) and N,N′,N′-tetranaphthyl-benzidine (TNB) (¶ [0589]). Cui teaches a charge generation layer comprising a benzodithiophene or its analogous structure compound, which can be used for the p-type charge generation layer in tandem OLEDs structure and can provide better device performance, for example, to further improve the voltage, efficiency and/or lifetime of the OLEDs (¶ [0013]). Cui teaches wherein the p-type charge generation layer further comprises at least one hole transporting material and is formed by doping the compound of Formula 1, and more specifically Formula 1', in at least one hole transporting material (¶ [0134] and ¶ [0028]) and teaches specific examples of the compound of Formula 1' including Compound 56 PNG media_image1.png 355 312 media_image1.png Greyscale (¶ [0241]), Compound 68 (¶ [0249]), and Compound 70 (¶ [0257]), each of which meet the claimed Formula (II). Therefore, it would have been obvious to one of ordinary skill in the pertinent art before the effective filing date of the claimed invention to have modified the device of Ganier by forming the p-type dopant out of the compound of Formula 1', as taught by Cui. One would have been motivated to do so because Ganier teaches the p-type CGL comprises a p-type dopant which may be conventional materials and Cui teaches the compound of Formula 1' for use as a dopant in a p-type charge generation layer in tandem OLED structure. The selection of a known material, which is based upon its suitability for the intended use, is within the ambit of one of ordinary skill in the pertinent art. See MPEP § 2144.07. Additionally, Cui teaches that the compound can provide better device performance, for example, to further improve the voltage, efficiency and/or lifetime of the OLED and therefore forming the p-type dopant out of the compound of Formula 1', as taught by Cui, in the device of Ganier would yield the benefit of improved the voltage, efficiency and/or lifetime, as described above. The modified device of Ganier in view of Cui meets claims 1-15. Conclusion The prior art made of record and not relied upon is considered pertinent to applicant's disclosure: Hummert et al. US-20170373251-A1 teaches a [3]-radialene p-dopant wherein the [3]-radialene p-dopant is selected from compounds having a structure according to formula (I) (¶ [0004] and ¶ [0007]), cited on the IDS of 07/25/2023; and Cui et al. US-20200087311-A1, cited on the IDS of 07/25/2023, teaches a benzodithiophene analogue compound having Formula 1 which can be used for the p type charge generation layer in tandem OLEDs structure (¶ [003]-[0014]). Contact Information Any inquiry concerning this communication or earlier communications from the examiner should be directed to Elizabeth M. Dahlburg whose telephone number is 571-272-6424. The examiner can normally be reached Monday through Thursday, 9 a.m. to 4 p.m. ET, and alternate Fridays. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Jennifer Boyd can be reached at 571-272-7783. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /ELIZABETH M. DAHLBURG/Primary Examiner, Art Unit 1786
Read full office action

Prosecution Timeline

Jul 25, 2023
Application Filed
Jun 29, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12685017
COMPOUND AND ORGANIC LIGHT EMITTING DIODE COMPRISING SAME
5y 1m to grant Granted Jul 14, 2026
Patent 12680017
ORGANIC ELECTROLUMINESCENCE DEVICE AND POLYCYCLIC COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE
4y 7m to grant Granted Jul 14, 2026
Patent 12637466
BENZOCARBAZOLE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME
6y 6m to grant Granted May 26, 2026
Patent 12635403
ORGANIC ELECTROLUMINESCENCE DEVICE
6y 1m to grant Granted May 19, 2026
Patent 12635373
ORGANIC LIGHT EMITTING DIODE AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THEREOF
4y 10m to grant Granted May 19, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
50%
Grant Probability
97%
With Interview (+46.6%)
4y 7m (~1y 8m remaining)
Median Time to Grant
Low
PTA Risk
Based on 188 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month